Sakura Bio Overview
Sakura Bio has developed an off-the-shelf, naïve PBMC-derived allogeneic T-cell therapy to fight cancer — in particular, acute myeloid leukemia. The company's platform focuses on creating super-activated killer cells, an allogenic T-cell therapy produced via a simple, relatively short manipulation of naïve PBMCs. Sakura Bio's lead product, Super Activated Killer T-cell (SAK-T), is a unique T-cell population with superior anti-tumor cytotoxic activity and no toxicity of healthy tissue. In contrast to other T-cell-based products, such as CAR-T, SAK-T cells have a high safety profile, with no graft-versus-host disease, and can be developed as an off-the-shelf T-cell product. SAK-T's outstanding killing properties of leukemic cells led Sakura to choose acute myeloid leukemia as its first-in-human indication for SAK therapy.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $1.7M |
| Last funding | $1.7M |
| Stage | Pre-Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.sakurabio.com/ |
Locations
Jerusalem, Israel
Photos & Videos
No files yet
Sakura Bio Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesHealthcareLaboratoriesCore Technology
BiologicalsCellsTags (4)
cancercell-therapycancer-therapypharmaceuticalsSakura Bio Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Sakura Bio Lifecycle
Cumulative Funding Raised Over Time
All Events
Sakura Bio News
0 articlesNo news articles.
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Sakura Bio Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | video or image, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Creator | Ayelet Levi Shinebox |
| Creator email | yayhosh@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-03-17T00:00:00.000Z |
| Created | 2022-11-21T00:00:00.000Z |